secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZEVRA THERAPEUTICS, INC. (ZVRA)
CIK:        0001434647
Form:       8-K
Filed at:   2023-02-24T23:59:59+00:00
Accession:  0001437749-23-004450
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KemPharm changes name to Zevra Therapeutics; ticker to become ZVRA on March 1, 2023
--------------------------------------------------------------------------------

- Name change effective February 21, 2023 via Delaware certificate of amendment.
- Common stock ticker to change from KMPH to ZVRA on Nasdaq on or about March 1, 2023.
- No shareholder vote required; rights of shareholders, creditors, and CUSIP unchanged.
- Bylaws amended and restated to reflect new name; no other charter or bylaw changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434647/000143774923004450/0001437749-23-004450-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434647/000143774923004450/kmph20230220_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-004450

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer